Supplement and nutraceutical teams use PIPA platforms to discover bioactives, validate potential synergies, and substantiate claims. Science-led products, at commercial speed.

In nutraceuticals, evidence is the product. Every ingredient, dose, and synergy claim needs literature to stand behind it — and your competitors are getting faster at building that evidence.
Modern supplements aren't single-ingredient pills. They're stacks of bioactives with interactions, dose-dependencies, and stability concerns. Formulation is a combinatorial problem.
FDA enforcement, FTC actions, and state AGs are tightening the screws on supplement claims. The evidence package behind every SKU now needs to survive actual scrutiny.
The capabilities nutraceuticals R&D teams use most, and what they enable.
Every ingredient decision backed by primary literature. Dose-response, mechanism of action, safety margins — organized into a defensible evidence package before the product ships.
Find ingredient combinations that work together mechanistically. Our knowledge graph surfaces potential synergies at a scale no team could discover manually.
Predict how bioactives interact in a finished product. Identify degradation risks, incompatibilities, and stability concerns before you commit to a formulation.
Build regulator-ready evidence packages for every health claim. Structured dossiers that hold up to FDA, FTC, and state-level scrutiny.